LongueVue Capital, a New Orleans-based private equity firm focused on providing growth capital to middle-market companies, has made an investment in Pinnacle Clinical Research LLC, a multi-location site organization focused on therapeutic areas such as hepatology and non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Founded in 2016 and based in San Antonio, Pinnacle operates clinical trial sites across Texas with facilities in San Antonio, Austin and Georgetown with over 100 full-time employees. Pinnacle offers therapeutic area professionals as primary investigators, board-certified sub-investigators and a quality control, regulatory and study recruitment team to support clinical trial outcomes since 2016.

“Pinnacle’s sites are among the highest quality that I’ve worked with in my 30+ year career, and I firmly believe that LVC is the right partner to drive Pinnacle’s growth while delivering superior clinical trial outcomes,” says Adrian Otte, LVC’s life science operating partner.